2819. Clinical Outcomes of Fosfomycin Treatment in E. coli vs. Non-E. coli Enterobacterales Urinary Tract Infection

BACKGROUND: Oral fosfomycin tromethamine is considered a first-line agent for the treatment of uncomplicated acute cystitis in women according to the national Infectious Disease Society of America (IDSA) guideline. However, non-E. coli Enterobacterales urinary tract infection (UTI) pathogens exhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Traugott, Kristi, Lee, Grace, Groff, Lindsey, Aguilar, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678636/
http://dx.doi.org/10.1093/ofid/ofad500.2430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678636/
http://dx.doi.org/10.1093/ofid/ofad500.2430

Ejemplares similares